Equitable global COVID-19 vaccine allocation and distribution : obstacles, contrasting moral perspectives, ethical framework and current standpoints

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11240%2F21%3A10436751" target="_blank" >RIV/00216208:11240/21:10436751 - isvavai.cz</a>

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=ZMFPIQS0BI" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=ZMFPIQS0BI</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2478/ebce-2021-0015" target="_blank" >10.2478/ebce-2021-0015</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Equitable global COVID-19 vaccine allocation and distribution : obstacles, contrasting moral perspectives, ethical framework and current standpoints

Popis výsledku v původním jazyce

Accelerated COVID-19 vaccine development represents an important accomplishment and a milestone in the history of vaccine evolution. However, the vaccine&apos;s scarcity made its equitable global allocation and distribution ambiguous. Despite the initial pledges from wealthy countriesfor fairness and inclusivity towards the poorer ones, the policies followed diverged significantly. Wealthy countries have vastly superior access to vaccines in a reality likened to an ethical disaster. This paper calls for the need for fair global vaccine allocation and distribution and examines the barriers that were met along the way, originating from different points, such as the nationalistic approach on the matter that most wealthy countries have adopted or the inability of poor countries to purchase or manufacture vaccines. Further, a suggestion regarding the ethical principles and values that ought to guide global vaccine allocation and distribution is provided with a higher priority given to helping the worst-off, saving the most lives, protecting people in high risk, such as frontline healthcare professionals, and minimising social gaps, along with an ethical theoretical background for each prioritisation. It is not too late for wealthy countriesto realise that vaccine inequity prolongs pandemics, so that they change their policies in favour of the global common good that will not only provide immediate universal benefits but will also serve as a guide for future pandemic crises.

Název v anglickém jazyce

Equitable global COVID-19 vaccine allocation and distribution : obstacles, contrasting moral perspectives, ethical framework and current standpoints

Popis výsledku anglicky

Accelerated COVID-19 vaccine development represents an important accomplishment and a milestone in the history of vaccine evolution. However, the vaccine&apos;s scarcity made its equitable global allocation and distribution ambiguous. Despite the initial pledges from wealthy countriesfor fairness and inclusivity towards the poorer ones, the policies followed diverged significantly. Wealthy countries have vastly superior access to vaccines in a reality likened to an ethical disaster. This paper calls for the need for fair global vaccine allocation and distribution and examines the barriers that were met along the way, originating from different points, such as the nationalistic approach on the matter that most wealthy countries have adopted or the inability of poor countries to purchase or manufacture vaccines. Further, a suggestion regarding the ethical principles and values that ought to guide global vaccine allocation and distribution is provided with a higher priority given to helping the worst-off, saving the most lives, protecting people in high risk, such as frontline healthcare professionals, and minimising social gaps, along with an ethical theoretical background for each prioritisation. It is not too late for wealthy countriesto realise that vaccine inequity prolongs pandemics, so that they change their policies in favour of the global common good that will not only provide immediate universal benefits but will also serve as a guide for future pandemic crises.

Druh

J_SC - Článek v periodiku v databázi SCOPUS

CEP obor

—

OECD FORD obor

60301 - Philosophy, History and Philosophy of science and technology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Ethics and Bioethics (in Central Europe)

ISSN

1338-5615

e-ISSN

—

Svazek periodika

11

Číslo periodika v rámci svazku

3-4

Stát vydavatele periodika

SK - Slovenská republika

Počet stran výsledku

18

Strana od-do

163-180

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-85122867422